Cortrophin Gel is indicated for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis and excess urinary protein due to nephrotic syndrome.
Avalere’s examination of Medicare Part D plan tier placement of generic prescription drugs found that over time their percentage on generic tiers has declined from 65% in 2016 to 43% in 2022.
Kimmtrak is the first TCR therapeutic, the first bispecific T cell engager to treat a solid tumor and the first and only therapy for the treatment of unresectable or metastatic uveal melanoma to be approved by the FDA.
The American Pharmacists Association and the National Alliance of State Pharmacy Associations released the first Welcome To Pharmacy Workplace and Well-Being Reporting trends and findings report.